Drugs / Autologous peripheral blood stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03101163 | Dec 2015 → Jul 2022 | articular cartilage disorder | KLSMC Stem Cells, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous peripheral blood stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03101163 ↗ |
| Known as | PBSCs | “The safety and efficacy of intra-articular injections of peripheral blood stem cells (PBSCs) together with hyaluronic acid (HA) after subchondral drilling surgery will be evaluated” NCT03101163 ↗ |
| Modality | Cell therapy | “peripheral blood stem cells (PBSCs)” NCT03101163 ↗ |